{"meshTags":["Antineoplastic Agents, Hormonal","Antineoplastic Combined Chemotherapy Protocols","Breast Neoplasms","Female","Humans","Receptors, Estrogen","Tamoxifen","Treatment Outcome"],"meshMinor":["Antineoplastic Agents, Hormonal","Antineoplastic Combined Chemotherapy Protocols","Breast Neoplasms","Female","Humans","Receptors, Estrogen","Tamoxifen","Treatment Outcome"],"publicationTypes":["Journal Article","Review"],"abstract":"Breast cancer is one of the common cancers. Hormonal therapy along with surgery, chemotherapy, radiotherapy and targeted therapy are vital modalities for the management of breast cancer. Tamoxifen has been the most widely used hormonal therapy for more than two decades. In this article we review the benefits, dose, duration and timing of Tamoxifen therapy in patients with breast cancer.","title":"Tamoxifen for breast cancer.","pubmedId":"21180225"}